$0.53 EPS Expected for USG (USG), Amarin PLC Has 1.63 Sentiment

July 6, 2017 - By Richard Conner

Amarin Corporation plc is a biopharmaceutical firm with activities in lipid science focused on the commercialization and development of therapeutics for cardiovascular health. The company has market cap of $1.21 billion. The Firm operates through the development and commercialization of Vascepa segment. It currently has negative earnings. The Company’s lead product, Vascepa capsule, is approved by the United States Food and Drug Administration (FDA) for use as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia.

Analysts expect USG Corporation (NYSE:USG) to report $0.53 EPS on July, 25.They anticipate $0.07 EPS change or 15.22% from last quarter’s $0.46 EPS. USG’s profit would be $77.60M giving it 13.82 P/E if the $0.53 EPS is correct. After having $0.37 EPS previously, USG Corporation’s analysts see 43.24% EPS growth. The stock increased 0.45% or $0.13 during the last trading session, reaching $29.3. About shares traded. USG Corporation (NYSE:USG) has risen 0.17% since July 6, 2016 and is uptrending. It has underperformed by 16.53% the S&P500.

USG Corporation, through its subsidiaries, is a maker and distributor of building materials. The company has market cap of $4.29 billion. The Company’s divisions include Gypsum, Ceilings and USG Boral Building Products . It has a 21.13 P/E ratio. It produces a range of products for use in new residential, new nonresidential, and residential and nonresidential repair and remodel construction, as well as products used in certain industrial processes.

Among 15 analysts covering USG Corporation (NYSE:USG), 5 have Buy rating, 3 Sell and 7 Hold. Therefore 33% are positive. USG Corporation had 30 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has “Underperform” rating given on Tuesday, January 26 by Credit Suisse. The stock of USG Corporation (NYSE:USG) has “Sector Perform” rating given on Friday, October 23 by RBC Capital Markets. The stock has “Sector Perform” rating by RBC Capital Markets on Monday, February 8. Goldman Sachs maintained it with “Neutral” rating and $27 target in Wednesday, May 4 report. The stock of USG Corporation (NYSE:USG) earned “Equal Weight” rating by Barclays Capital on Friday, October 23. Credit Suisse initiated the stock with “Underperform” rating in Friday, June 23 report. The stock has “Outperform” rating by RBC Capital Markets on Tuesday, September 13. Jefferies maintained it with “Hold” rating and $3300 target in Friday, June 2 report. The firm has “Neutral” rating given on Thursday, October 8 by Goldman Sachs. On Monday, September 19 the stock rating was upgraded by Vertical Research to “Buy”.

Investors sentiment increased to 0.88 in Q4 2016. Its up 0.04, from 0.84 in 2016Q3. It improved, as 33 investors sold USG Corporation shares while 81 reduced holdings. 37 funds opened positions while 63 raised stakes. 124.79 million shares or 2.48% more from 121.78 million shares in 2016Q3 were reported. 39.00 million are owned by Berkshire Hathaway Inc. Northern Corp has 0% invested in USG Corporation (NYSE:USG) for 450,165 shares. 766,075 were accumulated by Goldman Sachs Grp Inc. Manufacturers Life Insur The has invested 0% in USG Corporation (NYSE:USG). Macquarie Group has 1.07 million shares for 0.06% of their portfolio. Voloridge Inv Management Lc owns 24,568 shares or 0.02% of their US portfolio. Alliancebernstein Limited Partnership owns 54,660 shares or 0% of their US portfolio. Financial Architects has 1,000 shares. Balyasny Asset Mngmt Lc holds 19,034 shares or 0% of its portfolio. Westpac Bk has invested 0% in USG Corporation (NYSE:USG). White Pine Com accumulated 1.71% or 109,515 shares. Gmt Cap holds 2.00M shares or 1.21% of its portfolio. Staley Cap Advisers invested in 1.15% or 415,000 shares. Voya Inv Ltd Limited Liability Company holds 0% or 27,223 shares in its portfolio. Tower Research Lc (Trc) stated it has 223 shares.

Since February 13, 2017, it had 1 insider buy, and 2 selling transactions for $1.55 million activity. Press Jeanette A. also sold $89,092 worth of USG Corporation (NYSE:USG) on Wednesday, June 7. Scanlon Jennifer F. bought $44,089 worth of stock. HILZINGER MATTHEW F sold 45,596 shares worth $1.50M.

Ratings analysis reveals 100% of Amarin’s analysts are positive. Out of 2 Wall Street analysts rating Amarin, 2 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. The lowest target is $5.0 while the high is $6.0. The stock’s average target of $5.50 is 29.41% above today’s ($4.25) share price. AMRN was included in 2 notes of analysts from October 5, 2016. As per Wednesday, October 5, the company rating was initiated by Cantor Fitzgerald. The firm has “Buy” rating given on Wednesday, October 19 by Citigroup.

Consonance Capital Management Lp holds 8.47% of its portfolio in Amarin Corporation plc (ADR) for 25.05 million shares. Oracle Investment Management Inc owns 7.94 million shares or 4.05% of their US portfolio. Moreover, Healthcare Value Capital Llc has 1.48% invested in the company for 450,000 shares. The Maryland-based Rock Springs Capital Management Lp has invested 1.03% in the stock. Broadfin Capital Llc, a New York-based fund reported 2.83 million shares.

The stock increased 0.95% or $0.04 during the last trading session, reaching $4.25. About 200 shares traded. Amarin Corporation plc (ADR) (AMRN) has risen 76.19% since July 6, 2016 and is uptrending. It has outperformed by 59.49% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.